Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$3.00 USD
-0.05 (-1.64%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.96 -0.04 (-1.33%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Bionano Genomics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BNGO 3.00 -0.05(-1.64%)
Will BNGO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNGO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNGO
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now
BNGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
Other News for BNGO
Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference | BNGO Stock News
Bionano Genomics (BNGO) Unveils Enhanced Genomic Analysis Software
Bionano Genomics announces release of latest versions of its VIA, Solve
Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, ...
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on ...